Dapo Ajayi is Vice President, Supply Chain at Johnson & Johnson Innovative Medicine. In this role, Dapo is responsible for the global, end-to-end manufacturing and supply management of J&J pharmaceutical brands. She is a member of the Pharmaceutical Group Operating Committee (GOC) and the Supply Chain Management Committee (SCMC).
Previously, Dapo served as Vice President, Technical Operations & Supply Chain Strategy at Johnson & Johnson where she was accountable for accelerating the delivery of our supply chain strategy and maximizing the collective impact of the Company’s Environmental Health and Safety (EHS), Engineering & Property Services (E&PS), Supply Chain Acceleration, and Strategy, Innovation & Deployment (SI&D) teams to improve its operational capabilities, strategically leverage its network and reinvest in areas for growth and innovation.
Prior to that, Dapo served as Vice President, Manufacturing & Technical Operations, Janssen Supply Chain, where she led the internal and external global manufacturing network and was responsible for the technical operations that, through cross-functional partnership, supported the organization’s continuous and transformational technology improvement, as well as delivery of the Janssen pipeline.
Dapo has spent her entire career in the pharmaceutical sector and has a broad business and technical background. She is a pharmacist and a graduate of the School of Pharmacy at The University of Wales, United Kingdom (UK). She has held a variety of senior technical and supply chain leadership roles, including Chief Procurement Officer for the global pharmaceutical company AstraZeneca. While there, she also led manufacturing sites in the UK and Puerto Rico and the Global External Sourcing group (responsible for all third-party suppliers in the supply chain). In addition, she spent time in the commercial business, where she headed a strategic marketing function for established brands and formed a new business unit.
Dapo was included on the 2019 PharmaVOICE 100 list of influential and inspirational leaders from the life sciences industry, in recognition of her contributions as a change agent who is helping to shape the future of the healthcare ecosystem.